US0028241000 - Common Stock
NYSE:ABT (2/6/2023, 12:31:54 PM)-0.82 (-0.73%)
|GICS Sector||Health Care|
|GICS Industry||Health Care Equipment & Supplies|
|Earnings (Last)||01-25 2023-01-25/bmo||Earnings (Next)||04-18 2023-04-18/amc|
|Ins Owners||0.51%||Inst Owners||73.13%|
Find more stocks on New York Stock Exchange, Inc.
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Park, Illinois. The firm operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.
100 Abbott Park Rd
ABBOTT PARK ILLINOIS 60064
CEO: Robert B. Ford
You can bet the farm on these companies' dividends.
All three belong to the elite group of stocks known as Dividend Kings.
Abbott Laboratories (ABT) has launched its TactiFlex ablation catheter (sensor enabled) in Europe after receiving CE Mark.The company said that TactiFlex can reduce procedure...
They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace.
The US FDA will reorganize its food safety division to consolidate several functions in the aftermath of 2022's baby formula shortage to prevent a similar occurrence.
Here you can normally see the latest stock twits on ABT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.